drugset / Trial / NCT00402805

Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy

NCT00402805

Phase 4 Completed 50 enrolled University Health Network, Toronto
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to test the specific humoral response after an intramuscular and intradermal influenza vaccination in lung transplant recipients

Timeline

Start
2006-10
Primary completion
2007-02
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intramuscular